文献速递颈动脉与弓上血管

颈动脉内膜切除术后胰岛素依赖型糖尿病的风险

Risk of insulin-dependent diabetes mellitus in patients undergoing carotid endarterectomy.
PubMed 文献 · J Vasc Surg · 2018-10-24

基于NSQIP血管模块2011-2015年16739例CEA患者,按症状状态分层比较无糖尿病、IDDM和NIDDM的30天结局。无症状IDDM患者30天卒中/死亡率为3.4%,高于无糖尿病者的1.5%(P<.001),校正后OR为2.3(95%CI 1.5-3.4);有症状患者中IDDM和NIDDM均与30天卒中/死亡无关。

要点

  • 无症状IDDM患者CEA后30天卒中/死亡风险显著高于无糖尿病者。
  • 无症状IDDM合并解剖高风险标准者30天卒中/死亡率达6.6%。
  • 有症状患者中IDDM和NIDDM均未显示与30天卒中/死亡独立相关。

核心结论

  • 无症状IDDM患者CEA后30天卒中/死亡率超过国际血管学会指南对无症状患者的可接受结局阈值。
  • 无症状IDDM患者可能无法从CEA获益,但需更多关于该人群颈动脉疾病自然史的数据。

研究设计与样本

  • 回顾性队列研究,数据来自NSQIP靶向血管模块2011-2015年。
  • 共纳入16739例CEA患者,其中无症状9784例(58%),有症状6955例。
  • 按术前症状状态分层,比较无糖尿病、NIDDM和IDDM患者的30天结局。
  • 主要终点为30天卒中/死亡。

主要发现

  • 无症状患者中,IDDM组30天卒中/死亡率为3.4%,无糖尿病组为1.5%(P<.001)。
  • 无症状患者中,NIDDM组30天卒中/死亡率为2.1%,与无糖尿病组1.5%相似(P=.1)。
  • 无症状IDDM合并解剖高风险标准者30天卒中/死亡率为6.6%。
  • 校正后,无症状IDDM与30天卒中/死亡相关(OR 2.3;95%CI 1.5-3.4;P<.001),NIDDM不相关(OR 1.4;95%CI 1.0-2.1;P=.1)。
  • 有症状患者中,IDDM和NIDDM的30天卒中/死亡率与无糖尿病者相似(4.9% vs 3.6%和4.0% vs 3.6%;均P>.1),校正后均无显著关联。

关键数值与推荐

  • 无症状IDDM患者30天卒中/死亡率3.4%超过国际血管学会指南对无症状患者的可接受结局阈值。
  • 无症状IDDM合并解剖高风险标准者30天卒中/死亡率6.6%。

临床怎么用

  • 对无症状IDDM患者行CEA决策时需谨慎评估,尤其合并解剖高风险标准者。
  • 有症状患者中IDDM或NIDDM不应单独作为排除CEA的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is conflicting evidence regarding the association of diabetes mellitus (DM) and insulin use with outcomes after carotid endarterectomy (CEA). Therefore, we sought to evaluate the risk of insulin-dependent DM (IDDM) and noninsulin-dependent DM (NIDDM) on 30-day outcomes after CEA. METHODS: We identified patients undergoing CEA from the Targeted Vascular module of the National Surgical Quality Improvement Program (2011-2015) and stratified patients on the basis of their preprocedural symptom status. We compared 30-day outcomes between nondiabetics and patients with NIDDM or IDDM, with 30-day stroke/death as the primary end point. RESULTS: Of 16,739 CEA patients, 9784 (58%) were asymptomatic, of whom 6720 (69%) had no diagnosis of DM, 1109 (11%) had IDDM, and 1955 (20%) had NIDDM. Of the 6955 symptomatic patients, 4982 (72%) had no diagnosis of DM, 810 (12%) had IDDM, and 1163 (17%) had NIDDM. Among asymptomatic patients, patients with IDDM experienced higher rates of 30-day stroke/death compared with those without DM (3.4% vs 1.5%; P < .001), whereas those with NIDDM experienced rates similar to those of patients without DM (2.1% vs 1.5%; P = .1). Moreover, asymptomatic patients with IDDM and an anatomic high-risk criterion experienced a 30-day stroke/death rate of 6.6%. After adjustment, IDDM was associated with 30-day stroke/death in asymptomatic patients compared with patients without DM (odds ratio, 2.3; 95% confidence interval, 1.5-3.4; P < .001), but NIDDM was not (odds ratio, 1.4; 95% confidence interval, 1.0-2.1; P = .1). In comparison, among symptomatic patients, those with IDDM and NIDDM experienced similar rates of 30-day stroke/death as patients without DM (4.9% vs 3.6% and 4.0% vs 3.6%; both P > .1). After adjustment, neither IDDM nor NIDDM was associated with 30-day stroke/death in symptomatic patients compared with symptomatic patients without DM. CONCLUSIONS: Rates of 30-day stroke/death after CEA in asymptomatic patients with IDDM exceed international vascular societies' guideline thresholds for acceptable outcomes in asymptomatic patients, especially those with anatomic high-risk criteria. Thus, asymptomatic patients with IDDM may not benefit from CEA, although more data are needed about the natural history of carotid disease in this population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Pothof AB, O'Donnell TFX, Swerdlow NJ, et al. Risk of insulin-dependent diabetes mellitus in patients undergoing carotid endarterectomy. J Vasc Surg. 2018. PMID: 30714571. doi:10.1016/j.jvs.2018.05.250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。